483
Jae S. Cho, M.DFDA 483 - Jae S. Cho, M.D - December 31, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Jae S. Cho, M.D. at University Hospitals Cleveland Medical Center in Cleveland, OH, revealed significant deficiencies in clinical study conduct. The firm failed to adhere to protocol for reporting serious adverse events, with multiple instances of delayed entry into the electronic database. Additionally, the study utilized informed consent documents that were not approved by the IRB and were improperly altered by the study coordinator.
Open in Dashboard
ID · 5aeb9376-8422-432e-a918-36ab89d57ba1